Modulation of primary stem cell differentiation using an insulin-like growth factor binding protein
US6841386B2 · kind B2 · utility
23Cited by
8References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 2001 |
| Grant date | Jan 11, 2005 |
| Priority date | — |
| Expiry date | Sep 24, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/105
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention features methods of modulating primary stem cell differentiation in culture by altering the endogenous activity of an insulin-like growth factor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.